Jane Street
FTH

Jane Street’s Faeth Therapeutics FTH Stock Holding History

Jane Street’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$280K Buy
+8,872
New +$177K ﹤0.01% 9376
2022
Q3 		– Sell
-696
Closed -$32K – 10412
2022
Q2 		$32K Buy
696
+158
+29% +$5.92K ﹤0.01% 9041
2022
Q1 		$25K Buy
+538
New +$42.8K ﹤0.01% 9883
2021
Q4 		– Sell
-539
Closed -$113K – 10771
2021
Q3 		$113K Buy
+539
New +$98.1K ﹤0.01% 9228

Other funds holding FTH

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Jane Street's FTH Position: Q1 2026 in Review

Jane Street opened a new position in Faeth Therapeutics (FTH) in Q1 2026: 8,872 shares worth $280K. The stake represents ﹤0.01% of the portfolio and ranks #9376 among its holdings. This is a return to the name: Jane Street previously reported a position in FTH as recently as Q2 2022.

Jane Street first reported a position in FTH in Q3 2021 and has held it in 4 quarters since. 30 funds tracked by Wall St. Rank hold FTH as of Q1 2026.

  • Jane Street held 8,872 shares of Faeth Therapeutics worth $280K as of Q1 2026.
  • Faeth Therapeutics was a new Jane Street position in Q1 2026.
  • Faeth Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9376 holding.
  • Jane Street first reported a position in Faeth Therapeutics in Q3 2021 and has held it in 4 quarters since.
  • 30 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.